首页> 美国卫生研究院文献>Maxillofacial Plastic and Reconstructive Surgery >Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca
【2h】

Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca

机译:干燥性角结膜炎严重病例中的微血管自体颌下腺移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dry eye syndrome is a relatively common disease of the tears and ocular surfaces that results in discomfort, visual disturbance, and tear film instability with possible damage to the ocular surfaces. Microvascular submandibular gland (SMG) transfer offers a surgical alternative for a permanent autologous substitution of tears using the basal secretion of a transplanted SMG. Long-term follow-up reveals that this technique is a lasting and effective solution for patients with severe dry eye syndrome. The uncomfortable symptoms were relieved, and the frequency of use of pharmaceutical tear substitutes was reduced. Objective examination showed significant improvement in tear film and some features of ocular surface such as breakup time of tear film and corneal staining. Patients may suffer from obstruction of Wharton's duct or epiphora after surgery. Activation of secretion-related receptors could improve the early hypofunction of the denervated SMG and prevent the duct obstruction. Reduction surgery, partial SMG transplantation, uses of atropine gel or Botulinum toxin A could be the choices of treatment for epiphora.
机译:干眼症是泪液和眼表相对常见的疾病,会导致不适,视觉障碍和泪膜不稳定,并可能损坏眼表。微血管颌下腺(SMG)转移为外科手术提供了一种替代方法,可使用移植的SMG的基础分泌物永久性地自发替代眼泪。长期随访表明,该技术对于患有严重干眼症的患者是一种持久而有效的解决方案。缓解了不适的症状,并减少了使用药用眼泪替代品的频率。客观检查显示泪膜有明显改善,眼表有一些特征,例如泪膜破裂时间和角膜染色。手术后患者可能会受到沃顿管或泪溢的阻塞。分泌相关受体的激活可以改善失神经的SMG的早期功能减退,并防止导管阻塞。复位手术,部分SMG移植,使用阿托品凝胶或肉毒杆菌毒素A可能是治疗泪溢的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号